Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
15 p, 745.4 KB Chronic kidney disease has a graded association with death and cardiovascular outcomes in stable coronary artery disease : An analysis of 21,911 patients from the CLARIFY registry / Vidal-Petiot, Emmanuelle (Institut nationale de la santé et de la recherché médicale) ; Greenlaw, Nicola (University of Glasgow) ; Kalra, Paul R. (Portsmouth Hospitals NHS Trust) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Tardif, Jean-Claude (Université de Montreal) ; Ford, Ian (University of Glasgow) ; Zamorano, Jose (Hospital Universitari Ramon y Cajal) ; Ferrari, Roberto (Maria Cecilia Hospital) ; Tendera, Michal (Medical University of Silesia) ; Fox, Kim M. (Royal Brompton Hospital (Londres)) ; Steg, Philippe Gabriel (Hôpital Bichat) ; Universitat Autònoma de Barcelona
Chronic kidney disease (CKD) is associated with an increased cardiovascular risk in a broad spectrum of populations. However, the risk associated with a reduced estimated glomerular filtration rate (eGFR) in patients with stable coronary artery disease receiving standard care in the modern era, independently of baseline cardiovascular disease, risk factors, and comorbidities, remains unclear. [...]
2020 - 10.3390/jcm9010004
Journal of clinical medicine, Vol. 9 Núm. 1 (january 2020) , p. 4  
2.
12 p, 648.4 KB Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome / Bittner, Vera A. (University of Alabama at Birmingham) ; Szarek, Michael (State University of New York) ; Aylward, Philip (South Australian Health and Medical Research Institute) ; Bhatt, Deepak L. (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ; Díaz, Rafaël J. (Instituto Cardiovascular de Rosario) ; Edelberg, Jay M. (Sanofi) ; Fras, Zlatko (Univerza V Ljubljani) ; Goodman, Shaun G. (University of Toronto) ; Halvorsen, Sigrun (University of Oslo) ; Hanotin, Corinne (Sanofi) ; Harrington, Robert A. (Stanford University) ; Jukema, J. Wouter (Leiden University Medical Center) ; Loizeau, Virginie (Sanofi) ; Moriarty, Patrick Maurice (University of Kansas Medical Center) ; Moryusef, Angèle (Sanofi) ; Pordy, Robert (Regeneron Pharmaceuticals Inc.) ; Roe, Matthew T. (Duke University School of Medicine) ; Sinnaeve, Peter (University of Leuven) ; Tsimikas, Sotirios (University of California San Diego) ; Vogel, Robert A. (University of Colorado School of Medicine) ; White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ; Zahger, Doron (Soroka University Medical Center) ; Zeiher, Andreas Michael (Goethe University) ; Steg, Philippe Gabriel (Royal Brompton Hospital (Londres)) ; Schwartz, Gregory G. (University of Colorado School of Medicine) ; Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ; Cequier, Ángel (Hospital Universitari de Bellvitge) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona
Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). [...]
2020 - 10.1016/j.jacc.2019.10.057
Journal of the American College of Cardiology, Vol. 75 Núm. 2 (21 2020) , p. 133-144  

Vegeu també: autors amb noms similars
4 Steg, P.G.
1 Steg, P.Gabriel
1 Steg, Ph Gabriel
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.